CatalystPit

ASNDAscendis Pharma A/S

NASDAQ · Pharmaceutical Preparations
Last close $227.83 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-09-09 · Bodenhoff Mads (SVP & PAO) · OTHER
  • 2026-09-09 · Bodenhoff Mads (SVP & PAO) · SELL
  • 2026-09-03 · HOLTUG LARS (Director) · SELL
  • 2026-08-18 · BIENAIME JEAN JACQUES (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders90
Shares held35,379,306
Value$9.38B
Percent of shares outstanding57.08%
As of quarter end2026-06-30
RECENT NEWS
  • Ascendis to present hypoparathyroidism and achondroplasia data at ASBMR 2026
  • Ascendis Pharma authorizes $400M share buyback
  • Ascendis Pharma (ASND) Will Regain Metabolic Drug Rights. Is Greater Ownership Worth the Cost?
  • Ascendis Pharma returns to full independence
  • H.C. Wainwright reiterates Ascendis Pharma stock rating on Novo deal end
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Ascendis Pharma A/S (ASND) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit